BR0017198A - Formulation comprising thymol useful in treating drug resistant bacterial infections - Google Patents
Formulation comprising thymol useful in treating drug resistant bacterial infectionsInfo
- Publication number
- BR0017198A BR0017198A BR0017198-0A BR0017198A BR0017198A BR 0017198 A BR0017198 A BR 0017198A BR 0017198 A BR0017198 A BR 0017198A BR 0017198 A BR0017198 A BR 0017198A
- Authority
- BR
- Brazil
- Prior art keywords
- formulation
- useful
- bacterial infections
- resistant bacterial
- treating drug
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- 208000035143 Bacterial infection Diseases 0.000 title abstract 3
- 208000022362 bacterial infectious disease Diseases 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 3
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 title 2
- 239000005844 Thymol Substances 0.000 title 1
- 229960000790 thymol Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 244000302413 Carum copticum Species 0.000 abstract 1
- 235000007034 Carum copticum Nutrition 0.000 abstract 1
- 206010059866 Drug resistance Diseases 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 240000007707 Mentha arvensis Species 0.000 abstract 1
- 235000018978 Mentha arvensis Nutrition 0.000 abstract 1
- 235000016278 Mentha canadensis Nutrition 0.000 abstract 1
- 244000024873 Mentha crispa Species 0.000 abstract 1
- 235000014749 Mentha crispa Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000001220 mentha spicata Substances 0.000 abstract 1
- 229930003658 monoterpene Natural products 0.000 abstract 1
- 150000002773 monoterpene derivatives Chemical class 0.000 abstract 1
- 235000002577 monoterpenes Nutrition 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
"FORMULAçãO COMPREENDENDO TIMOL úTIL NO TRATAMENTO DE INFECçõES BACTERIANAS RESISTENTES A DROGA". Nova formulação útil no tratamento de infecções bacterianas resistentes a drogas compreendendo uma quantidade eficaz de "Timol" obtido da planta Trychyspermum ammi, combinação de óleo de menta contendo quantidades apropriadas de monoterpenos obtido de Mentha spicata e Mentha arvensis e obtendo aditivos convencionais, um processo para a produção de formulação pela misturação dos ingredientes acima e um processo para o tratamento de resistência à droga em um paciente pela administração de uma quantidade terapeuticamente eficaz da dita formulação."FORMULATION UNDERSTANDING USEFUL TIMOL IN TREATMENT OF DRUG RESISTANT BACTERIAL INFECTIONS". New formulation useful in treating drug-resistant bacterial infections comprising an effective amount of "Timol" obtained from the Trychyspermum ammi plant, a combination of mint oil containing appropriate amounts of monoterpenes obtained from Mentha spicata and Mentha arvensis and obtaining conventional additives, a process for formulation production by mixing the above ingredients and a process for treating drug resistance in a patient by administering a therapeutically effective amount of said formulation.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2000/000033 WO2001072317A1 (en) | 2000-03-28 | 2000-03-28 | Formulation comprising thymol useful in the treatment of drug resistant bacterial infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0017198A true BR0017198A (en) | 2003-04-08 |
Family
ID=11076234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0017198-0A BR0017198A (en) | 2000-03-28 | 2000-03-28 | Formulation comprising thymol useful in treating drug resistant bacterial infections |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN100339069C (en) |
| BR (1) | BR0017198A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104803853B (en) * | 2014-01-29 | 2017-02-22 | 中国科学院海洋研究所 | Anti-Vibrio vulnificus monoterpene derivative, and preparation method and application thereof |
| CN108567814A (en) * | 2018-04-27 | 2018-09-25 | 江西中医药大学 | A kind of Herba Moslae volatile oil is for sterilizing and/or antibacterial, antimicrobial agent application and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU708703B2 (en) * | 1995-05-26 | 1999-08-12 | Ropapharm B.V. | Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field |
-
2000
- 2000-03-28 BR BR0017198-0A patent/BR0017198A/en not_active Application Discontinuation
- 2000-03-28 CN CNB008194823A patent/CN100339069C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN100339069C (en) | 2007-09-26 |
| CN1452491A (en) | 2003-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9709136A (en) | Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field. | |
| BR0116370A (en) | Compound, pharmaceutical composition, use of a compound, and method of treating an hppar-mediated disease or condition in a patient. | |
| BR0015974A (en) | Use of levetiracetam, pharmaceutical composition, use of a pharmaceutical composition and methods to treat a patient administered with an amount of at least one compound and a disease and to selectively potentiate the therapeutic effect of a compound | |
| BRPI0411484A (en) | compound, pharmaceutical formulation, methods of treating or preventing lipid disorders (dyslipidemia), and type 2 diabetes, use of a compound, and pharmaceutical composition | |
| BRPI0414428A (en) | pharmaceutical compositions | |
| BR0116169A (en) | Compound, pharmaceutical composition comprising such compound, process for preparing a pharmaceutical composition, use of the compounds, process for the prophylactic or therapeutic treatment of type ii diabetes and process for the preparation of the compound. | |
| PT1259512E (en) | PTERIDIN COMPOUNDS FOR PSORIASIS TREATMENT | |
| BR9913585A (en) | Formulation of stable liquid pharmaceutical botulinum toxin, method of treating a patient in need of inhibition of cholinergic entry into a selected muscle, muscle group, gland or organ, and use of a formulation of stable liquid botulinum toxin | |
| SE0001899D0 (en) | New compounds | |
| BR0212020A (en) | Dosage forms, methods for preventing abuse of a dosage form, methods for preventing diversion of a dosage form, methods for treating pain and method of preparing a dosage form | |
| BR0213540A (en) | Compounds, method for treating a patient's illness or disorder and a pharmaceutical composition comprising them | |
| BR0214289A (en) | Beverage composition comprising a defined boron compound, method of preparing it, kit comprising it and use thereof in the manufacture of a medicament | |
| AU4550801A (en) | Herbal composition phy906 and its use in chemotheraphy | |
| BRPI0510761A (en) | methods of treating a patient afflicted with at least one condition and reducing or eliminating wrinkles | |
| BR0312000A (en) | Compounds, pharmaceutical compositions, method for treating or prophylaxis of diseases, and use of the compounds | |
| KR970061244A (en) | Pharmaceutical composition for treating dementia | |
| BR0209128A (en) | Compounds, pharmaceutical compositions, methods for treating pain, methods for modulating a pharmacological response and uses of compounds | |
| BR0211936A (en) | Use of glycosamine and a selective cyclooxygenase-2 inhibitor or prodrug thereof in the manufacture of a medicament as well as a pharmaceutical composition and kit comprising the same | |
| BRPI0409881A (en) | compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds | |
| BR0017198A (en) | Formulation comprising thymol useful in treating drug resistant bacterial infections | |
| BR9915900A (en) | Compound, pharmaceutical composition, and process for treating or inhibiting disorders associated with smooth muscle contraction. | |
| BRPI0407529A (en) | use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain | |
| AR028987A1 (en) | COMPOSITE DERIVED FROM CYCLOPENTAPIRIDIN-KETONE, PHARMACEUTICAL COMPOSITION CONTAINING IT AND ITS USE IN THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT TO TREAT A DISEASE | |
| BRPI0407569A (en) | use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders | |
| DK1212072T3 (en) | Pharmaceutical composition comprising eucalyptus and orange oil |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ART. 8O COMBINADO COM ART. 13 E ART. 10 DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 35/00 (2006.01) |